Evidence map›Paper›PMID 34870347›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2022

An Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia.

Fahad Aljuraibah, Justine Bacchetta, Maria Luisa Brandi, Pablo Florenzano, Muhammad K Javaid, Outimaija Mäkitie, Adalbert Raimann, Mariano Rodriguez, Heide Siggelkow, Dov Tiosano and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Supplements for bone health.Archives of endocrinology and metabolism · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Updates on renal phosphate transport.Current opinion in nephrology and hypertension · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The basics of phosphate metabolism.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 12 institutions in 12 countries.

Fahad AljuraibahCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Justine BacchettaHôpital Femme Mère Enfant, INSERM1033 Research Unit, Bron, France.
Maria Luisa BrandiUniversity of Florence, Florence, Italy.
Pablo FlorenzanoPontificia Universidad Católica de Chile, Santiago, Chile.ORCID 0000-0001-5936-3146
Muhammad K JavaidUniversity of Oxford, Oxford, UK.ORCID 0000-0001-7985-0048
Outimaija MäkitieChildren's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0002-4547-001X
Adalbert RaimannMedical University of Vienna, Vienna, Austria.
Mariano RodriguezHospital Universitario Reina Sofia, IMIBIC, Córdoba, Spain.
Heide SiggelkowUniversity Medical Center, Göttingen, Germany.
Dov TiosanoRambam Medical Center, Haifa, Israel.
Marc VervloetAmsterdam University Medical Center, Amsterdam, The Netherlands.
Carsten A WagnerUniversity of Zurich, Zurich.ORCID 0000-0002-9874-8898
Amsterdam University Medical Centers · NLInserm · FRInstituto Maimónides de Investigación Biomédica de Córdoba · ESKing Saud bin Abdulaziz University for Health Sciences · SAMedical University of Vienna · ATPontificia Universidad Católica de Chile · CLRambam Health Care Campus · ILUniversitätsmedizin Göttingen · DEUniversity of Florence · ITUniversity of Helsinki · FIUniversity of Oxford · GBUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because of their rarity, diseases characterized by chronic hypophosphatemia can be underrecognized and suboptimally managed, resulting in poor clinical outcomes. Moreover, serum phosphate may not be measured routinely in primary care practice. Authors participated in several working sessions to advance the understanding of phosphate homeostasis and the causes, consequences, and clinical implications of chronic hypophosphatemia. Phosphate levels are regulated from birth to adulthood. Dysregulation of phosphate homeostasis can result in hypophosphatemia, which becomes chronic if phosphate levels cannot be normalized. Chronic hypophosphatemia may be underrecognized as serum phosphate measurement is not always part of routine analysis in the primary care setting and results might be misinterpreted, for instance, due to age-specific differences not being accounted for and circadian variations. Clinical consequences of chronic hypophosphatemia involve disordered endocrine regulation, affect multiple organ systems, and vary depending on patient age and the underlying disorder. Signs and symptoms of chronic hypophosphatemic diseases that manifest during childhood or adolescence persist into adulthood if the disease is inadequately managed, resulting in an accumulation of clinical deficits and a progressive, debilitating impact on quality of life. Early identification and diagnosis of patients with chronic hypophosphatemia is crucial, and clinical management should be started as soon as possible to maximize the likelihood of improving health outcomes. Furthermore, in the absence of a universally accepted description for "chronic hypophosphatemia," a definition is proposed here that aims to raise awareness of these diseases, facilitate diagnosis, and guide optimal phosphate management strategies by improving monitoring and assessment of patient response to treatment. © 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

Indexed as

Familial Hypophosphatemic RicketsHypophosphatemiaOsteomalaciaAdolescentAdultFibroblast Growth FactorsHumansPhosphatesQuality of LifeFibroblast Growth FactorsPhosphatesHYPOPHOSPHATEMIAOSTEOMALACIA AND RICKETSPARATHYROID HORMONE/VITAMIN D/FIBROBLAST GROWTH FACTOR 23PHOSPHATE HOMEOSTASIS

Identifiers

PMID34870347
PMCPMC9306528
OpenAlexW4200179450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.